TGAオーストラリア供給不足情報(2025年8月18日~8月24日)

Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
methylphenidate hydrochlorideCapsule, hard20 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/08/2025
prazosin hydrochlorideTablet, uncoated2.19 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply22/08/2025
Pancreatic extractCapsule, enteric300 mgCurrentLimited AvailabilityUnexpected increase in consumer demand22/08/2025
magnesium chloride hexahydrate~sodium lactate~calcium chloride dihydrate~glucose~sodium chlorideSolution, irrigation50.8 mg/L~4.48 g/L~183 mg/L~25 g/L~5.38 g/LCurrentLimited AvailabilityManufacturing22/08/2025
fampridineTablet, modified release10 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues22/08/2025
propranolol hydrochlorideTablet, film coated40 mgCurrentUnavailableManufacturing22/08/2025
fluticasone propionate~salmeterol xinafoateInhalation, powder for250 microgram/actuation~72.5 microgram/actuationCurrentLimited AvailabilityUnexpected increase in consumer demand22/08/2025
fluticasone propionate~salmeterol xinafoateInhalation, pressurised125 microgram/actuation~36.3 microgram/actuationAnticipatedAvailableUnexpected increase in consumer demand22/08/2025
rifampicinCapsule300 mgCurrentLimited AvailabilityManufacturing22/08/2025
atorvastatin calcium trihydrateTablet, film coated86.76 mgCurrentUnavailableManufacturing22/08/2025
Pancreatic extractCapsule420 mgCurrentLimited AvailabilityUnexpected increase in consumer demand22/08/2025
aciclovirEye Ointment.135 gAnticipatedAvailableManufacturing22/08/2025
spironolactoneTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing22/08/2025
tobramycinInhalation, conventional60 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability22/08/2025
fentanylDrug delivery system, transdermal16.8 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply21/08/2025
mycophenolate mofetilTablet, film coated500 mgAnticipatedAvailableManufacturing21/08/2025
entecavirTablet, film coated1 mgAnticipatedAvailableManufacturing21/08/2025
sugammadex sodiumInjection, solution217.6 mgAnticipatedAvailableManufacturing21/08/2025
rifampicinCapsule, hard150 mgAnticipatedAvailableManufacturing21/08/2025
ropivacaine hydrochlorideInjection, solution7.5 mg/mLResolvedAvailableUnexpected increase in consumer demand21/08/2025
gramicidin~dexamethasone~framycetin sulfateEar Drops.05 mg/mL~.5 mg/mL~5 mg/mLResolvedAvailableManufacturing20/08/2025
midazolamInjection, solution5 mg/mLCurrentLimited AvailabilityManufacturing20/08/2025
tramadol hydrochlorideTablet, modified release200 mgCurrentLimited AvailabilityManufacturing20/08/2025
clopidogrel hydrogen sulfateTablet, film coated97.875 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply20/08/2025
ciprofloxacin hydrochlorideTablet, film coated555 mgCurrentUnavailableManufacturing20/08/2025
risperidoneTablet, film coated.5 mgCurrentUnavailableManufacturing20/08/2025
carboplatinInjection, solution450 mgCurrentLimited AvailabilityManufacturing20/08/2025
pemetrexed disodiumInjection, powder for1102.9 mgCurrentUnavailableManufacturing20/08/2025
mesalazineTablet, enteric coated800 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues20/08/2025
solifenacin succinateTablet10 mgCurrentLimited AvailabilityManufacturing20/08/2025
levothyroxine sodiumTablet100 microgramResolvedAvailableUnexpected increase in consumer demand20/08/2025
levothyroxine sodiumTablet75 microgramResolvedAvailableManufacturing20/08/2025
dexamethasone~gramicidin~framycetin sulfateEar Drops.5 mg/mL~.05 mg/mL~5 mg/mLResolvedAvailableManufacturing20/08/2025
trandolaprilCapsule, hard2 mgCurrentUnavailableManufacturing20/08/2025
tetrabenazineTablet, uncoated25 mgAnticipatedAvailableManufacturing19/08/2025
valaciclovirTablet, film coated500 mgCurrentLimited AvailabilityManufacturing19/08/2025
benzathine benzylpenicillin tetrahydrateInjection, suspension1200000 USP UnitCurrentUnavailableManufacturing19/08/2025
pioglitazone hydrochlorideTablet, uncoated33.06 mgResolvedAvailableManufacturing19/08/2025
sodium chloride~sodium lactate~calcium chloride dihydrate~glucose~magnesium chloride hexahydrateSolution, irrigation5.38 g/L~4.48 g/L~183 mg/L~15 g/L~50.8 mg/LCurrentLimited AvailabilityManufacturing19/08/2025
acetylcysteineInjection, concentrated2 gResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply19/08/2025
paclitaxelInjection, concentrated300 mgCurrentLimited AvailabilityManufacturing19/08/2025
oxycodone hydrochlorideCapsule, hard10 mgResolvedAvailableCommercial Changes / Commercial viability19/08/2025
betamethasone dipropionate~calcipotriolFoam264 microgram/g~20.5 microgram/gResolvedAvailableTransport / Logistic issues / Storage capacity issues19/08/2025
clonidine hydrochlorideTablet100 microgramCurrentLimited AvailabilityManufacturing19/08/2025
nitisinoneTablet2 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/08/2025
encorafenibCapsule, hard50 mgResolvedAvailableManufacturing19/08/2025
celecoxibCapsule, hard100 mgCurrentUnavailableManufacturing19/08/2025
mesalazineTablet, enteric coated1.6 gAnticipatedAvailableTransport / Logistic issues / Storage capacity issues19/08/2025
lurasidone hydrochlorideTablet, film coated40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/08/2025
lurasidone hydrochlorideTablet, film coated80 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/08/2025
GluureaLys(ahx)hbedCCInjection, powder for25 microgramCurrentUnavailableManufacturing19/08/2025
proguanil hydrochloride~atovaquoneTablet, film coated100 mg~250 mgCurrentLimited AvailabilityManufacturing19/08/2025
tetrabenazineTablet, uncoated25 mgAnticipatedAvailableManufacturing19/08/2025
TeriparatideInjection, solution250 microgram/mLCurrentUnavailableManufacturing19/08/2025
aripiprazole monohydrateInjection, powder for416.07 mgCurrentUnavailableManufacturing19/08/2025
spironolactoneTablet, film coated25 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply19/08/2025
tobramycinInhalation, conventional300 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing18/08/2025
mupirocin calciumOintment21.5 mg/gResolvedAvailableManufacturing18/08/2025
lurasidone hydrochlorideTablet, film coated40 mgCurrentUnavailableManufacturing18/08/2025
clopidogrel hydrogen sulfateTablet, film coated97.875 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply18/08/2025
2025年8月25日
このページの先頭へ戻る